These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31630219)

  • 1. A statistical model for activation of Factor C by binding to LPS aggregates.
    Miyagawa Y; Kikuchi K; Tsuchiya M; Adachi S
    Eur Biophys J; 2019 Dec; 48(8):743-747. PubMed ID: 31630219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermolecular autocatalytic activation of serine protease zymogen factor C through an active transition state responding to lipopolysaccharide.
    Shibata T; Kobayashi Y; Ikeda Y; Kawabata SI
    J Biol Chem; 2018 Jul; 293(29):11589-11599. PubMed ID: 29866883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding lipopolysaccharide aggregation and its influence on activation of Factor C.
    Wang C; Nelson T; Chen D; Ellis JC; Abbott NL
    J Colloid Interface Sci; 2019 Sep; 552():540-553. PubMed ID: 31154247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definition of endotoxin binding sites in horseshoe crab factor C recombinant sushi proteins and neutralization of endotoxin by sushi peptides.
    Tan NS; Ng ML; Yau YH; Chong PK; Ho B; Ding JL
    FASEB J; 2000 Sep; 14(12):1801-13. PubMed ID: 10973930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of recombinant factor C assay for the detection of divergent lipopolysaccharide structural species and comparison with Limulus amebocyte lysate-based assays and a human monocyte activity assay.
    Abate W; Sattar AA; Liu J; Conway ME; Jackson SK
    J Med Microbiol; 2017 Jul; 66(7):888-897. PubMed ID: 28693666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limulus clotting factor C: lipopolysaccharide-sensitive serine protease zymogen.
    Muta T; Tokunaga F; Nakamura T; Morita T; Iwanage S
    Methods Enzymol; 1993; 223():336-45. PubMed ID: 8271961
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on lipopolysaccharide-sensitive serine protease zymogen (factor C): its isolation from Limulus polyphemus hemocytes and identification as an intracellular zymogen activated by alpha-chymotrypsin, not by trypsin.
    Tokunaga F; Nakajima H; Iwanaga S
    J Biochem; 1991 Jan; 109(1):150-7. PubMed ID: 2016264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of the clip domains of two protease zymogens in the coagulation cascade in horseshoe crabs.
    Yamashita K; Shibata T; Takahashi T; Kobayashi Y; Kawabata SI
    J Biol Chem; 2020 Jun; 295(26):8857-8866. PubMed ID: 32409575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular mechanism of interaction between sushi peptide and Pseudomonas endotoxin.
    Li P; Sun M; Wohland T; Ho B; Ding JL
    Cell Mol Immunol; 2006 Feb; 3(1):21-8. PubMed ID: 16549045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular serine-protease zymogen, factor C, from horseshoe crab hemocytes. Its activation by synthetic lipid A analogues and acidic phospholipids.
    Nakamura T; Tokunaga F; Morita T; Iwanaga S; Kusumoto S; Shiba T; Kobayashi T; Inoue K
    Eur J Biochem; 1988 Sep; 176(1):89-94. PubMed ID: 3166424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor B Is the Second Lipopolysaccharide-binding Protease Zymogen in the Horseshoe Crab Coagulation Cascade.
    Kobayashi Y; Takahashi T; Shibata T; Ikeda S; Koshiba T; Mizumura H; Oda T; Kawabata S
    J Biol Chem; 2015 Jul; 290(31):19379-86. PubMed ID: 26109069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity LPS binding domain(s) in recombinant factor C of a horseshoe crab neutralizes LPS-induced lethality.
    Tan NS; Ho B; Ding JL
    FASEB J; 2000 May; 14(7):859-70. PubMed ID: 10783139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structural perspective on the interaction between lipopolysaccharide and factor C, a receptor involved in recognition of Gram-negative bacteria.
    Koshiba T; Hashii T; Kawabata S
    J Biol Chem; 2007 Feb; 282(6):3962-7. PubMed ID: 17135239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and properties of monoclonal antibodies against lipopolysaccharide-sensitive serine protease zymogen, factor C, from horseshoe crab (Tachypleus tridentatus) hemocytes.
    Miura Y; Tokunaga F; Miyata T; Moriyasu M; Yoshikawa K; Iwanaga S
    J Biochem; 1992 Oct; 112(4):476-81. PubMed ID: 1283392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant factor C competes against LBP to bind lipopolysaccharide and neutralizes the endotoxicity.
    Li P; Ho B; Ding JL
    J Endotoxin Res; 2007; 13(3):150-7. PubMed ID: 17621557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical characterization of the interaction of Limulus polyphemus endotoxin neutralizing protein with lipopolysaccharide.
    Andrä J; Garidel P; Majerle A; Jerala R; Ridge R; Paus E; Novitsky T; Koch MH; Brandenburg K
    Eur J Biochem; 2004 May; 271(10):2037-46. PubMed ID: 15128313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between lipopolysaccharide and intracellular serine protease zymogen, factor C, from horseshoe crab (Tachypleus tridentatus) hemocytes.
    Nakamura T; Tokunaga F; Morita T; Iwanaga S
    J Biochem; 1988 Feb; 103(2):370-4. PubMed ID: 3163690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin.
    Brandenburg K; Jürgens G; Müller M; Fukuoka S; Koch MH
    Biol Chem; 2001 Aug; 382(8):1215-25. PubMed ID: 11592403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor C acts as a lipopolysaccharide-responsive C3 convertase in horseshoe crab complement activation.
    Ariki S; Takahara S; Shibata T; Fukuoka T; Ozaki A; Endo Y; Fujita T; Koshiba T; Kawabata S
    J Immunol; 2008 Dec; 181(11):7994-8001. PubMed ID: 19017991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose phosphorylated on carbon 6 suppresses lipopolysaccharide binding to lipopolysaccharide-binding protein and inhibits its bioactivities.
    Fujita Y; Yagi K
    Int Immunopharmacol; 2017 Apr; 45():43-52. PubMed ID: 28187312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.